13 May, EOD - Indian

SENSEX 81148.22 (-1.55)

Nifty 50 24578.35 (-1.39)

Nifty Bank 54940.85 (-0.80)

Nifty IT 37354.6 (-2.42)

Nifty Midcap 100 55520.7 (0.19)

Nifty Next 50 65065.8 (-0.02)

Nifty Pharma 21359.75 (1.22)

Nifty Smallcap 100 16903.4 (0.81)

13 May, EOD - Global

NIKKEI 225 38183.26 (1.43)

HANG SENG 23108.27 (-1.87)

S&P 5916.25 (0.67)

LOGIN HERE

companylogoJeevan Scientific Technology Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 538837 | NSE Symbol : | ISIN : INE237B01018 | Industry : Miscellaneous |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
01-Mar-2025 01-Mar-2025 EGM Outcome of the Board Meeting held on 01.03.2025
30-Jan-2025 06-Feb-2025 Quarterly Results Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months Ended 31.12.2025. Outcome of the Board Meeting held on 06.02.2025 (As Per Bse Announcement Dated on 06.02.2025)
02-Nov-2024 08-Nov-2024 Quarterly Results Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30.09.2024. 2. Limited Review Report for the quarter and half year ended 30.09.2024. 3. Any other business with the permission of the Chair. Outcome of the Board Meeting held on 08.11.2024 (As Per BSE Announcement dated on 08.11.2024)
03-Aug-2024 09-Aug-2024 Quarterly Results Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2024. 2. Any other business with the permission of the Chair. Outcome of Board Meeting for the quarter ended 30.06.2024 under regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015. Unaudited Financial Results for the quarter ended 30.06.2024 (As Per BSE Announcement Dated on 09.08.2024)
21-May-2024 30-May-2024 Accounts Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve 1. Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended 31.03.2024. 2. Audit Report (Standalone and Consolidated) for the year ended 31.03.2024. 3. Any other business with the permission of the Chair. Outcome of Board Meeting for the quarter and year ended 31.03.2024 under regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015. (As Per BSE Announcement Dated on 30.05.2024)
06-Feb-2024 14-Feb-2024 Quarterly Results Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. Unaudited Financial results (Standalone and Consolidated) for the quarter and nine months ended 31.12.2023. 2. Any other business with the permission of the Chair. With reference to the subject cited, this is to inform the exchange that the Board of Directors of Jeevan Scientific Technology Limited at its meeting held on Wednesday, the 14th day of February, 2024 at 04:30 P.M. at registered office of the Company for the quarter and nine months ended 31.12.2023 considered and approved the following: 1. Un- Audited Financial Results (standalone and consolidated) for the quarter and nine months ended 31.12.2023. (Attached) 2. Limited Review Report (standalone and consolidated) for the Quarter and nine months ended 31.12.2023. (Attached) (As per BSE Announcement Dated on 14/02/2024)
04-Nov-2023 13-Nov-2023 Quarterly Results Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2023 inter alia to consider and approve 1. Unaudited Financial results (Standalone and Consolidated) for the quarter and half year ended 30.09.2023. 2. Any other business with the permission of the Chair. Outcome of Board Meeting for the quarter ended 30.09.2023 under regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015. Outcome of the Board Meeting (As Per BSE Announcement Dated on 13/11/2023)
07-Aug-2023 14-Aug-2023 Quarterly Results Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve 1. Unaudited Financial results (Standalone and Consolidated) for the quarter ended 30.06.2023. 2. To decide on the day date time and venue of 25th Annual General Meeting for FY 2022-2023. 3. To consider and approve the Notice of the 25th Annual General meeting for the Financial Year 2022-2023 and other related matters thereto. 4. To consider and approve Directors Report and the annexures thereon for the Financial Year 2022-2023. 5. Appointment of Scrutinizer for the e-voting process on resolutions proposed at the ensuing Annual General Meeting. 6. Any other business with the permission of the Chair. Outcome of the Board Meeting held on 14.08.2023 (As Per BSE Announcement Dated on 14.08.2023)
20-May-2023 27-May-2023 Quarterly Results Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 inter alia to consider and approve 1. Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended 31.03.2023. 2. Audit Report (Standalone and Consolidated) for the year ended 31.03.2023. 3. Any other business with the permission of the Chair. Outcome of Board Meeting for the quarter and year ended 31.03.2023 under Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015. (As Per BSE Announcement Dated on 27.05.2023)
21-Mar-2023 27-Mar-2023 Subsidiary Company Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2023 inter alia to consider and approve Intimation of Board Meeting to be held on 27.03.2023. Outcome of Board Meeting held on 27.03.2023 (As Per BSE Announcement Dated on 27.03.2023)
01-Feb-2023 08-Feb-2023 Quarterly Results Quarterly Results Outcome of Board Meeting held on 08.02.2023 Copy of Un-audited Financial Results for the Quarter and Nine Months Ended 31st December 2022 (As per BSE Announcement Dated on 08/02/2023)
04-Nov-2022 11-Nov-2022 Quarterly Results Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve 1. Un-audited Financial Results for the quarter and half year ended 30.09.2022. 2. Limited Review Report for the quarter ended 30.09.2022. 3. Any other business with the permission of the Chair. With reference to the subject cited, this is to inform the exchange that the Board Meeting of Jeevan Scientific Technology Limited held on Friday, 11-November-2022 at the registered office of the company, approved the following items of business: ] 1. Un-audited Financial Results for the quarter and half year ended 30th September 2022. (Enclosed as Annexure I). 2. Limited Review Report for the Quarter and half year ended 30th September 2022. (Enclosed as Annexure II). 3. To acquire 80% of the Shareholding by way of Investment of Rs. 2.00 Crores in Nayas Laboratories Private Limited, subject to the approval of Shareholders. Both the companies (Investing and Investee Companies) have the common promoters and the directors and hence amounts to related party transaction (Enclosed relevant disclosures as Annexure III). 4. Extra Ordinary General Meeting is scheduled to be held on Monday, 12.12.2022 at 10:30 a.m. through video conference or other audio - visual means. Please find enclosed herewith a Copy of Unaudited Financial Results for the Quarter and Half Year Ended 30 September, 2022 which were taken on record by the Board of Directors at their Meeting held on 11 November, 2022. (As Per BSE Announcement dated on 11.11.2022)
04-Aug-2022 12-Aug-2022 Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve 1. Un-audited Financial Results for the quarter ended 30.06.2022. 2. Limited Review Report for the quarter ended 30.06.2022. 3. Re-appointment of Mr. K. Rama Krishna Prasad as Director Retires by Rotation. 4. Re appointment of M/s. Pavuluri & Co. as Statutory Auditors of the Company. 5. To decide on the day date time and venue of Annual General Meeting for FY 2021-22. 6. Notice of 24th Annual General Meeting for the Financial Year 2021-22. 7. Directors Report and annexures for the Financial Year 2021-22. 8. Appointment of Scrutinizer for the e voting process on resolution proposed at the ensuing Annual General Meeting. 9. Any other business with the permission of the Chair. Outcome of Board Meeting held on 12.08.2022 Unaudited Financial Results for the Quarter Ended 30th June, 2022. Resignation of Mr. Srikanth Sasidhar Mathamsetty, Chief Financial Officer of the Company w.e.f. 16.09.2022. Appointment of Mr. K. Jeevan Krishna as Chief Financial Officer of the Company w.e.f. 16.09.2022. As a result, he will act as Executive Director cum CFO. (As per BSE Announcement Dated on 12/08/2022) Copy of Newspaper Cuttings of Unaudited Financial Results for the Quarter Ended 30th June, 2022. (As Per BSE Announcement Dated on 13/08/2022)
19-May-2022 30-May-2022 Accounts Audited Results Jeevan Scientific Technology Ltd has informed BSE that the Board Meeting of the Company will be held on May 30, 2022, inter alia, to take on record the following: 1. Audited Financial Statements for the quarter and year ended March 31, 2022 including recommendation of dividend, if any. 2. Audit Report for the year ended March 31, 2022. 3. Appointment of Secretarial Auditor for the F.Y. 2022-23, 4. Appointment of Internal Auditor for the F.Y. 2022-23. (As Per BSE Announcement Dated on 19-05-2022) The Board Meeting to be held on 30/05/2022 has been revised to 30/05/2022 The meeting of Board of Directors of the Company has been rescheduled on the same day i.e., Monday, May 30, 2022 at 11:30 a.m. instead of 03:00 p.m. (As Per BSE Announcement Dated on 20.05.2022) Board approved and recommended a dividend of 12% at the BM held on 30-May-2022 Outcome of Board Meeting Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31.03.2022 Jeevan Scientific Technology Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2022, inter alia, has recommended a Final Dividend of Rs. 1.20/- per share subject to approval of members at the ensuing Annual General Meeting. Board has granted 76,000 options to the eligible employees of the company pursuant to JSTL ESOP Scheme 2016 as recommended by Nomination and Remuneration Committee. (Refer Annexure - A) (As Per BSE Announcement Dated on 30.05.2022) With reference to results dated 30-May-2022, for FY 2021-22, the company is attaching herewith the statement of Assets and Liabilities and Cash flow on consolidated basis as suggested by BSE vide mail dated 07-Jun-2022. The company had earlier uploaded the complete results and there are no deviations / changes in the financial results. The earlier results did not consist of the statement of Assets and Liabilities and Cash flow on consolidated basis since the subsidiaries of the company were sold on 31-Jan-2022 and ceased to be subsidiaries of the company as on 31-Mar-2022. (As Per BSE Announcement dated on 08.06.2022)
20-Apr-2022 20-Apr-2022 Others Following items of business were approved: 1. Proposal for expansion of business via pursuing pharma and bio-science (manufacturing) domain within the ambit of Memorandum of Association and authorisation to Mr. K. Krishna Kishore, Vice- Chairman and Managing Director of the company to submit a report thereon to the Board. 2. Purchase the property located at 3rd Floor, North Block, Raghava Ratna Towers, Chirag Ali Lane, Abids, Hyderabad- 500001. 3. To provide Inter-Corporate Deposit of Rs. 3.00 Crores to M/s. Tanvi Foods (India) Ltd.
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +